Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about DK:NOVO/B

Recent news which mentions DK:NOVO/B

Novo Nordisk, now Europe’s second-largest company by market cap, lifts outlook after 46% profit rise
Tickers NVO
Tags NVO DK:NOVO/B
From MarketWatch
Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes
Tickers LLY NVO SPX VKTX
Tags SPX LLY XBI
From MarketWatch
As obesity drugs help people eat less, these food companies could be the biggest losers
Tickers ACI BJ BRBR CAVA
Tags SG CPB MDLZ
From MarketWatch
Eli Lilly’s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook
Tickers DJIA JNJ LLY MRK
Tags PFE NVO LLY
From MarketWatch
Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults
Tickers LLY NVO PFE
Tags PFE NVO LLY
From MarketWatch
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
Tickers ALT CTLT GPCR LLY
Tags UK:AZN ALT CTLT
From MarketWatch
EU regulator is reviewing weight-loss drugs Ozempic and Wegovy for risk of suicidal thoughts and self-harm
Tickers LLY PFE
Tags DK:NOVO/B LLY PFE
From MarketWatch
Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid
Tickers LLY PFE RAD
Tags DK:NOVO/B RAD PFE
From MarketWatch
Student-loan payments are coming back — and these are the stocks most at risk
Tickers AAPL AEO AMC BABA
Tags TSLA PAU23 PLN23
From MarketWatch
Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says
Tickers LLY NVO
Tags LLY NVO DK:NOVO/B
From MarketWatch
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
Tickers ETNB GNFT ICPT LLY
Tags ICPT TERN DK:NOVO/B
From MarketWatch
Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter
Tickers LLY SPX
Tags SPX DK:NOVO/B LLY
From MarketWatch
Novo Nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts
Tickers NVO
Tags NVO DK:NOVO/B
From MarketWatch
Novo Nordisk lifts guidance as earnings beat expectations
Tickers FDS NVO
Tags DK:NOVO/B NVO FDS
From MarketWatch
Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity
Tickers LLY SPX
Tags LLY DK:NOVO/B SPX
From MarketWatch
‘There’s no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used?
Tickers LLY
Tags LLY DK:NOVO/B
From MarketWatch
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
Tickers ABBV AZN BMY LLY
Tags BMY ABBV UK:GSK
From MarketWatch
Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’
Tickers ESALY LLY PFE SPX
Tags ESALY SPX DK:NOVO/B
From MarketWatch
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
Tickers AAPL AMC AZN BABA
Tags RUT IONS CORT
From MarketWatch
European stocks advance after partial Russian troop withdrawal
Tags DK:NOVO/B NO:EQNR FR:FTI
From MarketWatch
GlaxoSmithKline shares soar after Unilever bids for its consumer healthcare unit
Tickers GSK NVO PFE PG
Tags FR:PX1 UK:UKX GSK
From MarketWatch
European stocks inch closer to all-time high, inspired by Wall Street optimism
Tickers ASML NVO SPX
Tags XX:SXXP SPX FR:PX1
From MarketWatch
Germany is getting a new chancellor. Here’s how the DAX has performed under outgoing Angela Merkel
Tickers BNTX NSRGY NVO PFE
Tags EURUSD XX:SXXP BNTX
From MarketWatch
European markets drift lower, as healthcare stocks retreat
Tags ES:IBE FR:PX1 XX:SXXP
From MarketWatch
Bank of America downgrades U.K. stocks and reiterates overweight on Spain, Italy and Germany
Tags DX:DAX DK:NOVO/B UK:UKX
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.